Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiation Therapy (SBRT)
It is reported that more than 90,000 patients died of lung cancer and more than 20% of them
were older than 80 years in North America. Therefore a less invasive but effective treatment
is required for patients with lung cancer of advanced age, diminished pulmonary functions,
and chronic diseases. Stereotactic body radiation therapy (SBRT) is an effective and
well-tolerated treatment for early stage lung cancer in medically inoperable patients. On
the other hand, accurate mediastinal and hilar lymph node staging is one of the most
important factors that determine the outcome and indications for SBRT. Endobronchial
ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a novel, minimally
invasive modality that enables the assessment of mediastinal and hilar lymph nodes with a
high sensitivity. Accurate lymph node staging by EBUS-TBNA will allow opportunities for
high-risk patients with lung cancer to undergo minimally invasive treatment.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society